• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » BBK Worldwide supports “Boston Strong” at DIA

BBK Worldwide supports “Boston Strong” at DIA

June 21, 2013
CenterWatch Staff

BBK is empowering attendees of DIA’s 49th annual meeting, in Boston June 23-27, to support victims of the Boston Marathon attacks. In the spirit of using “mobile for good”—and leveraging BBK’s mobile platform—meeting attendees can text “Boston Strong” to 617-706-4000 any time during the conference.

“Boston Strong” has become the rallying cry in the aftermath of the attacks, inspiring courage, compassion and strength. For each text received, BBK and contributing companies will donate $5 to The One Fund Boston—a victim relief fund established by Massachusetts Governor Deval Patrick and Boston Mayor Thomas Menino to raise money for victims and families affected by the attacks.

The DIA meeting brings together more than 7,000 life science professionals involved in the discovery, development and life cycle management of new treatment options. “The DIA members represent an industry whose scientific and medical achievements have played a tremendous role in advancing the way the survivors have been, and will continue to be, treated,” said Joan F. Bachenheimer, founding principal, BBK Worldwide.

BBK is inviting other exhibiting companies to donate to the effort and extend BBK’s original goal of $10,000. “We are pleased to announce that Infinata has contributed $5,000, and that Pearson, its parent company, has matched that amount,” said Bonnie A. Brescia, founding principal, BBK Worldwide.

“When we learned about BBK’s effort to mobilize the DIA community in support of Boston and The One Fund Boston, we immediately wanted to contribute and rallied other companies to do the same,” said Kristopher E. Sarajian, director of marketing and public relations, Infinata, which publishes BioPharm Insight and BioPharm Clinical.

ERT and Valesta Clinical Research Solutions, a division of On Assignment, also have contributed to the effort. Once the current goal of $22,000 is achieved, attendees will be given the opportunity to donate on their own by going to www.OneFundBoston.org.

“As we assemble in Boston, we couldn’t think of a more fitting tribute to honor the city and the victims of the Boston Marathon attacks,” said Eric Rosen, manager, public relations for DIA. “We value the tremendous initiative BBK has shown by launching this effort and their extension of goodwill to our members. We will be furthering their effort by paying tribute to those affected by the Boston Marathon attacks with a video that will be shown during the plenary session on Monday, June 24.”

Upcoming Events

  • 12Apr

    The Participant Playbook Webinar Series, Part 3 — Rethinking the Development of Participant-Centric Clinical Trial Technology

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

  • White House

    Trial Stakeholders Advise White House on Emergency Research Infrastructure

  • SurveywBlueBackground-360x240.png

    Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing